您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Levocabastine
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Levocabastine
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Levocabastine图片
CAS NO:79516-68-0
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
R 50547
产品介绍
Levocabastine (R 50547) 是一种强效选择性组胺 H1 受体拮抗剂。Levocabastine 也是一种选择性、高亲和力的神经降压素受体亚型 2(NTR2)拮抗剂,对 mNTR2 的Ki值为 17 nM。Levocabastine 可作为VLA-4拮抗剂,干扰过敏性结膜炎 (AC) 结膜嗜酸性粒细胞的浸润。
生物活性

Levocabastine (R 50547) is a potent and selectivehistamine H1-receptorantagonist. Levocabastine hydrochloride is also a selective, high affinityneurotensin receptorsubtype 2 (NTR2)antagonist, with aKiof 17 nM for mNTR2. Levocabastine can act as aVLA-4antagonist, interferes with conjunctival eosinophil infiltration in allergic conjunctivitis (AC)[1][2][3].

IC50& Target[1][2][3]

H1Receptor

 

α4β1

 

NTR2

17 nM (Ki)

体外研究
(In Vitro)

Levocabastine (0-1000 μM; HEK-293 cells) causes inhibition of125I-FN binding to the SPA bead-associated α4β1 integrin in a concentration-dependent manner with an IC50of 406.2μm[3].
Levocabastine (0-1000 μM; 30 min; Jurkat cells and EoL-1 cells) inhibits α4β1 integrin/VCAM-1-mediated cell adhesion in vitro. Levocabastine inhibits α4β1 integrindependent adhesion of Jurkat cells to VCAM-1 with an IC50of 395.6 μM, and the adhesion of EoL-1 cells with an IC50of 403.6 μM. Moreover, Levocabastine inhibits adhesion of human eosinophils to VCAM-1-coated wells (IC50=443.7 μM)[3].

体内研究
(In Vivo)

Levocabastine (R 50547; 0.25 mg/kg; i.p.; twice a day for five days; guinea-pig with Parainfluenza-3 (PI-3) virus) inhibits the virus-induced airway hyperresponsiveness[1].
Levocabastine (0.05 mg/kg; i.p.; once; male C57BL/6J mice) blocks anti-stress effect ofβ-LT on mouse behavior[2].
Levocabastine (500 μg/eye; drops eye; once; ovalbumin-sensitized guinea pigs) induces allergic conjunctivitis (AC) and a significant increase of conjunctival VLA-4[3].

Animal Model:Guinea-pig with Parainfluenza-3 (PI-3) virus[1]
Dosage:0.25 mg/kg
Administration:Intraperitoneal injection; twice a day for five days
Result:Suppressed the influx of broncho-alveolar cells and increased in albumin content.
Animal Model:Male C57BL/6J mice (8-9 weeks old)[2]
Dosage:0.05 mg/kg; 30 mg/kg (β-LT)
Administration:Intraperitoneal injection; once
Result:Blocked the anxiolytic effect of β-LT and decreased the number of head-dips.
Animal Model:Ovalbumin-sensitized guinea pigs[3]
Dosage:500 μg/eye
Administration:drops eye, once
Result:Produced a noteworthy protection from allergic conjunctivitis (AC) and prevented the conjuctival elevation of VLA-4 as well as conjunctival eosinophil infiltration.
Clinical Trial
分子量

420.52

Formula

C26H29FN2O2

CAS 号

79516-68-0

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.